The increasing complexity of cancer chemotherapy makes it mandatory that pharmacists be familiar with these highly toxic agents. This column reviews various issues related to the preparation, dispensing, and administration of cancer chemotherapy, both commercially available and investigational.
Get full access to this article
View all access options for this article.
References
1.
LevineM.N., BramwellV.V.H., PritchardK.I.Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamiide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. J Clin Oncol.1998; 16(8): 2651–8.
2.
CookA.M., ChambersE.J., ReesG.J.G.Comparison of mitozantrone and epirubicin in advanced breast cancer [abstract]. Br J Cancer.1995; 72(suppl 25); 34.
3.
CarmichaelJ., JonesA.Hutchinson T. A Phase II trial of epirubicin plus paclitaxel in metastatic breast cancer. United Kingdom Coordinating Committee for Cancer Research Breast Cancer Subcommittee. Seminars Oncol.1997; 24(suppl 17): S17-44–S17-47.
4.
WilsJ., van GeunsH., StootJ.Cyclophosphamide, epirubicin and cisplatin (CEP) versus epirubicin plus cisplatin (EP) in stage Ic-IV ovarian cancer: A randomized phase III trial of the Gynecologic Oncology Group of the Comprehensive Cancer Center Limburg. Anticancer Drugs.1999; 10(3): 257–61.
5.
ZiberaC., PedrazzoliP., PonchioL.Efficacy of epirubicin/paclitaxel combination in mobilizing large amounts of hematopoietic progenitor cells in patients with metastatic breast cancer showing optimal response to the same chemotherapy regimen. Haematologica.1999; 84(10): 924–9.
6.
RothA., KolaricK., ZupancD.High doses of 5-fluorouracil and epirubicin with or without cisplatin in advanced gastric cancer: A randomized study. Tumori.1999; 85(4): 234–8.
7.
Ali-El-DeinB., NabeehA., IsmailE-HSequential bacillus Calmette-Guerin and epirubicin versus bacillus Calmette-Guerin alone for superficial bladder tumors: A randomized prospecitve study. J Urol.1999; 162(2): 339–42.
8.
MelekosM.D., DauaherH., FokaefsE.Intravesical instillaiton of 4-epidoxorubicin (epirubicin) in the prophylactic treatment of superficial bladder cancer: Results of a controlled prospective study. J Urol.1992; 147: 371–5.
9.
Ali-El-DeinB., El-BazM., AlyA.N.M.Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages Pta and pT1): A randomized prospective study. J Urol.1997; 158: 68–74.
10.
WollP.J., JudsonI., LeeS.M.Temozolomide in adult patients with advanced soft tissue sarcoma: A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer.1999; 35(3): 410–2.
11.
NewlandsE.S., O'ReillyS.M., GlaserM.G.The Charing Cross Hospital experience with temozolomide in patients with gliomas. Eur J Cancer.1996; 32A(13): 2236–41.
12.
MiddletonM.R., GrobJ.J., AaronsonN.Randomized Phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol.2000; 18(1): 158–66.
13.
BrockC.S., NewlandsE.S., WedgeS.R.Phase I trial of temozolomide using an extended continuous oral schedule. Cancer Res.1998; 58(19): 4363–7.
